Century Therapeutics, Inc. (IPSC) Institutional Ownership

Ownership Summary

Century Therapeutics, Inc. (NASDAQ:IPSC) showed up in the 13F filings of 45 institutional investors as of December 2025.

• These investors held 29.6% of outstanding shares in December 2025, up from 23.4% in September 2025.
• Their total shares held in IPSC increased 67.61% from the prior quarter, while the number of investors in Century Therapeutics decreased 37.5% year over year.
• Of these 45 funds, 17 grew their exposure to Century Therapeutics, 12 cut back, and 16 maintained positions.
• In total, institutional investors held 25.63Mn shares in Century Therapeutics as of December 2025, up by 10.34Mn shares quarter on quarter, and down 11.37Mn shares year over year.
• TCG Crossover Management, LLC holds the largest position in IPSC at 17.75Mn shares as of December 31, 2025, or 20.53% of shares outstanding.
• Leading buyers of Century Therapeutics shares for the quarter ending December 2025 were TCG Crossover Management, LLC (17.75Mn), RA CAPITAL MANAGEMENT, L.P. (17.75Mn), Versant Venture Management, LLC (12.17Mn), Deep Track Capital, LP (9.49Mn), Venrock Adviser, LLC (8.7Mn).
• Leading sellers of Century Therapeutics shares for the quarter ending December 2025 were ACADIAN ASSET MANAGEMENT LLC (939.03K), RENAISSANCE TECHNOLOGIES LLC (442.37K), DAFNA Capital Management LLC (359.23K), SUPERSTRING CAPITAL MANAGEMENT LP (343.66K), GSA CAPITAL PARTNERS LLP (256.36K).
• According to Business Quant data, leading holders of IPSC for December 2025 are TCG Crossover Management, LLC (17.75Mn), RA CAPITAL MANAGEMENT, L.P. (17.75Mn), Versant Venture Management, LLC (12.17Mn), Deep Track Capital, LP (9.49Mn), Venrock Adviser, LLC (8.7Mn), Commodore Capital LP (8.7Mn), RTW INVESTMENTS, LP (8.7Mn), Point72 Asset Management, L.P. (5.96Mn), VANGUARD CAPITAL MANAGEMENT LLC (5.69Mn), BALYASNY ASSET MANAGEMENT L.P. (5.02Mn).